Loading...
CRISPR/Cas9 for the treatment of haematological diseases: A journey from bacteria to the bedside
Genome editing therapies represent a significant advancement in next-generation, precision medicine for the management of haematological diseases, and CRISPR/Cas9 has to date been the most successful implementation platform. From discovery in bacteria and archaea over 3 decades ago, through intensiv...
Na minha lista:
| Udgivet i: | Br J Haematol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8118330/ https://ncbi.nlm.nih.gov/pubmed/32506752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16807 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|